Drug Information

Drug General Information
Drug ID
D08TVI
Former ID
DNCL001938
Drug Name
HPP-854
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 1 [523704]
Company
High Point Pharmaceuticals
Target and Pathway
Target(s) Beta-secretase Target Info Modulator [533118]
References
Ref 523704ClinicalTrials.gov (NCT01482013) Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease. U.S. National Institutes of Health.
Ref 533118BACE1 inhibitor drugs in clinical trials for Alzheimer's disease. Alzheimers Res Ther. 2014 Dec 24;6(9):89.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.